Related Experiment Videos
Estrogen, prolactin, and autoimmunity: actions and interactions.
1Division of Rheumatology and Molecular Immunology, Department of Medicine, L525 Clinical Sciences Building, University of Mississippi Medical Center and Rheumatology Section, G.V. (Sonny) Montgomery VA Hospital, Jackson, MS 39216, USA. rupus1@aol.com
International Immunopharmacology
|June 16, 2001
Summary
Estrogen and prolactin influence autoimmunity through complex immune interactions. Reducing prolactin with bromocriptine successfully suppressed autoimmune disease in models and humans.
Area of Science:
- Endocrinology
- Immunology
- Autoimmunity
Background:
- Estrogen and prolactin exhibit reciprocal endocrine relationships with significant effects on the immune system.
- The precise mechanisms by which these hormones modulate autoimmunity remain incompletely understood.
- Both hormones influence cell-mediated and humoral immunity, as well as interferon-gamma secretion.
Purpose of the Study:
- To elucidate the distinct roles of estrogen and prolactin in autoimmune disease pathogenesis.
- To investigate the therapeutic potential of modulating these hormonal pathways in autoimmune conditions.
Main Methods:
- Review of experimental models, human autoimmune diseases, and pregnancy in autoimmune patients.
- Analysis of hormonal effects on immune responses, including cell-mediated immunity, humoral immunity, IL-2 production, and IFN-gamma secretion.
- Evaluation of pharmacological interventions targeting estrogen and prolactin, such as bromocriptine.
Main Results:
- Prolactin accelerates autoimmune disease, as observed in the NZB x NZW F1 mouse model of lupus.
- Estrogen, when its prolactin-stimulating properties are removed, demonstrates immunosuppressive effects, inhibiting IL-2 production.
- Pharmacological reduction of prolactin levels using bromocriptine has shown success in suppressing autoimmune disease development and expression in both murine and human studies.
Conclusions:
- Estrogen and prolactin exert dichotomous effects on autoimmune responses, complicating direct hormonal manipulation.
- Targeting and reducing immunostimulatory prolactin concentrations represents a viable therapeutic strategy for autoimmune diseases.
- Further research into estrogen-prolactin interactions is crucial for understanding the female predominance in autoimmunity and developing targeted hormonal immunotherapies.